XML 43 R22.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Segment Information | 12 Months Ended
--- | ---
Dec. 31, 2017
Segment Reporting [Abstract] |
Segment Information | Segment Information The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia. The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes. The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation costs and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments. Approximately 75% of the Company’s Net sales are generated from markets outside the U.S., with approximately 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). Oral, Personal and Home Care sales to Wal-Mart Stores, Inc. and its affiliates represent approximately 11% of the Company’s Net sales in 2017. No other customer represents more than 10% of Net sales. In 2017, Corporate Operating profit (loss) includes charges of $333 resulting from the Global Growth and Efficiency Program. In 2016, Corporate Operating profit (loss) includes charges of $228 resulting from the Global Growth and Efficiency Program and $17 for a litigation matter and a gain of $97 on the sale of land in Mexico. In 2015, Corporate Operating profit (loss) included charges of $1,084 related to the deconsolidation of the Company’s Venezuelan operations, $254 related to the Global Growth and Efficiency Program, $34 related to the remeasurement of CP Venezuela’s local currency-denominated net monetary assets as a result of effective devaluations and $14 for a litigation matter and a gain of $187 on the sale of the Company’s laundry detergent business in the South Pacific.
|  | 2017 |  | 2016 |  | 2015
Net sales |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |
North America(1) |  | $ | 3,117 |  |  | $ | 3,183 |  |  | $ | 3,149 |
Latin America |  | 3,887 |  |  | 3,650 |  |  | 4,327 |
Europe |  | 2,394 |  |  | 2,342 |  |  | 2,411 |
Asia Pacific |  | 2,781 |  |  | 2,796 |  |  | 2,937 |
Africa/Eurasia |  | 983 |  |  | 960 |  |  | 998 |
Total Oral, Personal and Home Care |  | 13,162 |  |  | 12,931 |  |  | 13,822 |
Pet Nutrition(2) |  | 2,292 |  |  | 2,264 |  |  | 2,212 |
Total Net sales |  | $ | 15,454 |  |  | $ | 15,195 |  |  | $ | 16,034 |
_________
(1) | Net sales in the U.S. for Oral, Personal and Home Care were $2,865, $2,932 and $2,896 in 2017, 2016 and 2015, respectively.
(2) | Net sales in the U.S. for Pet Nutrition were $1,246, $1,243 and $1,223 in 2017, 2016 and 2015, respectively.
|  | 2017 |  | 2016 |  | 2015
Operating profit |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |  |  |
North America |  | $ | 986 |  |  | $ | 1,030 |  |  | $ | 974 |
Latin America |  | 1,162 |  |  | 1,132 |  |  | 1,209 |
Europe |  | 599 |  |  | 579 |  |  | 615 |
Asia Pacific |  | 841 |  |  | 887 |  |  | 888 |
Africa/Eurasia |  | 179 |  |  | 186 |  |  | 178 |
Total Oral, Personal and Home Care |  | 3,767 |  |  | 3,814 |  |  | 3,864 |
Pet Nutrition |  | 653 |  |  | 653 |  |  | 612 |
Corporate |  | (831 | ) |  | (630 | ) |  | (1,687 | )
Total Operating profit |  | $ | 3,589 |  |  | $ | 3,837 |  |  | $ | 2,789 |
|  | 2017 |  | 2016 |  | 2015
Capital expenditures |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |  |  |
North America |  | $ | 74 |  |  | $ | 151 |  |  | $ | 207 |
Latin America |  | 127 |  |  | 94 |  |  | 110 |
Europe |  | 63 |  |  | 51 |  |  | 40 |
Asia Pacific |  | 125 |  |  | 120 |  |  | 121 |
Africa/Eurasia |  | 13 |  |  | 17 |  |  | 12 |
Total Oral, Personal and Home Care |  | 402 |  |  | 433 |  |  | 490 |
Pet Nutrition |  | 33 |  |  | 38 |  |  | 34 |
Corporate |  | 118 |  |  | 122 |  |  | 167 |
Total Capital expenditures |  | $ | 553 |  |  | $ | 593 |  |  | $ | 691 |
|  | 2017 |  | 2016 |  | 2015
Depreciation and amortization |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |  |  |
North America |  | $ | 58 |  |  | $ | 54 |  |  | $ | 47 |
Latin America |  | 82 |  |  | 76 |  |  | 88 |
Europe |  | 74 |  |  | 64 |  |  | 67 |
Asia Pacific |  | 101 |  |  | 96 |  |  | 99 |
Africa/Eurasia |  | 8 |  |  | 7 |  |  | 8 |
Total Oral, Personal and Home Care |  | 323 |  |  | 297 |  |  | 309 |
Pet Nutrition |  | 53 |  |  | 53 |  |  | 52 |
Corporate |  | 99 |  |  | 93 |  |  | 88 |
Total Depreciation and amortization |  | $ | 475 |  |  | $ | 443 |  |  | $ | 449 |
|  | 2017 |  | 2016 |  | 2015
Identifiable assets |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |
North America |  | $ | 2,608 |  |  | $ | 2,685 |  |  | $ | 2,622 |
Latin America |  | 2,423 |  |  | 2,314 |  |  | 2,314 |
Europe |  | 3,781 |  |  | 3,554 |  |  | 3,308 |
Asia Pacific |  | 2,244 |  |  | 2,006 |  |  | 2,031 |
Africa/Eurasia |  | 544 |  |  | 499 |  |  | 476 |
Total Oral, Personal and Home Care |  | 11,600 |  |  | 11,058 |  |  | 10,751 |
Pet Nutrition |  | 1,026 |  |  | 1,009 |  |  | 1,006 |
Corporate(1) |  | 50 |  |  | 56 |  |  | 178 |
Total Identifiable assets(2) |  | $ | 12,676 |  |  | $ | 12,123 |  |  | $ | 11,935 |
____________
(1) | In 2017, Corporate identifiable assets primarily consist of derivative instruments (5%) and investments in equity securities (86%). In 2016, Corporate identifiable assets primarily consist of derivative instruments (24%) and investments in equity securities (68%). In 2015, Corporate identifiable assets primarily consist of derivative instruments (76%) and investments in equity securities (23%).
(2) | Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-third of total long-lived assets of $7,908, $7,642 and $7,420 in 2017, 2016 and 2015, respectively.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration